By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
NeoStem, Inc.'s Lead Immuno-Oncology Product Candidate, NBS20, Receives ATMP Classification From The European Medicines Agency 4/27/2015 8:29:29 AM
Onconova Therapeutics Inc. (ONTX) Submits Pivotal Clinical Trial Protocol For IV Rigosertib In Higher-Risk Myelodysplastic Syndromes To FDA And European Medicines Agency 4/20/2015 8:04:34 AM
European Medicines Agency's PRAC Recommends Updating Advice On Use Of High Dose Ibuprofen 4/13/2015 9:50:02 AM
Mesoblast Limited (MSB.AX) Phase 3 Program For Degenerative Disc Disease To Include European Sites After Positive Meeting With European Medicines Agency 4/8/2015 7:14:13 AM
Repros Therapeutics Inc. (RPRX) Receives Confirmation Of Eligibility For Submission Of A Centralized Marketing Authorization Application To The European Medicines Agency As A New Active Substance 4/7/2015 7:10:26 AM
European Medicines Agency Release: Making A Difference To Human And Animal Health 3/31/2015 8:46:07 AM
European Medicines Agency Commences Review Of CSL Behring's Regulatory Submission For Rix-FP For Hemophilia B Patients 3/30/2015 12:50:45 PM
Biogen (BIIB) Announces European Medicines Agency Validation Of Marketing Authorization Application For SB2, A Biosimilar Candidate For Infliximab 3/30/2015 12:48:01 PM
European Medicines Agency Validates Marketing Authorisation Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment Of MS 3/27/2015 11:22:50 AM
European Medicines Agency Release: Gardasil 9 Offers Wider Protection Against Cancers Caused By Human Papillomavirus (HPV) 3/27/2015 9:22:47 AM